Thromboembolic events in postmenopausal women receiving hormone replacement therapy (HRT) v no HRT*

Study typeNumber of studiesRelative risk (95% credible interval)†
*A random effects model was used.
†Credible interval is the range within which a 95% chance exists of finding the true relative risk.
Randomised controlled trial33.75 (1.2 to 10.3)
Cohort study12.10 (1.2 to 3.8)
Case control study82.05 (1.4 to 2.6)
All studies122.14 (1.6 to 2.8)